OSE Immunotherapeutics Reports Full Year 2023 Financial Results and Provides Business Strategy Update - sharewise
| OSE Stock | EUR 7.80 0.41 4.99% |
About 61% of OSE Pharma's investor base is looking to short. The analysis of current outlook of investing in OSE Pharma SA suggests that many traders are alarmed regarding OSE Pharma's prospects. The current market sentiment, together with OSE Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use OSE Pharma SA stock news signals to limit their universe of possible portfolio assets.
OSE |
OSE Immunotherapeutics Reports Full Year 2023 Financial Results and Provides Business Strategy Update sharewise
Read at news.google.com
 |
OSE Pharma Fundamental Analysis
We analyze OSE Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OSE Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OSE Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
OSE Pharma is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
OSE Pharma SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OSE Pharma stock to make a market-neutral strategy. Peer analysis of OSE Pharma could also be used in its relative valuation, which is a method of valuing OSE Pharma by comparing valuation metrics with similar companies.
Peers
OSE Pharma Related Equities
| IPH | Innate Pharma | 22.58 | ||||
| VLA | Valneva SE | 0.54 | ||||
| NANO | Nanobiotix | 2.13 | ||||
| POXEL | Poxel SA | 7.69 |
Complementary Tools for OSE Stock analysis
When running OSE Pharma's price analysis, check to measure OSE Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OSE Pharma is operating at the current time. Most of OSE Pharma's value examination focuses on studying past and present price action to predict the probability of OSE Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OSE Pharma's price. Additionally, you may evaluate how the addition of OSE Pharma to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges |